Investigation of the Effects of Diet on the Measurement of Plasma Chromogranin in NET Patients

Not Applicable

Completed

• Conditions: Neuroendocrine Tumors
• Interventions: Other: ongoing fasted state, intake of caffeine containing beverages or 5-item English breakfast

• Registration Number: NCT03288402
• Lead Sponsor: University Hospitals Coventry and Warwickshire NHS Trust

Brief Summary

Measurement of plasma chromogranin A remains the most commonly used biomarkers for both screening and monitoring of patients with gastro-entero-pancreatic neuroendocrine tumours (GEP-NET), despite several limitations that include: lack of a reference CgA standard; wide variations depending on the used assay in different laboratories; and varying sensitivity ranges from 60 to 90% with low specificity \<50%, depending on the population studied.

Surprisingly, and to the best of our knowledge, only three studies with small numbers of participants have been published that have investigated possible effects of food intake on the measurement of CgA. Most have been performed in healthy controls or patients on treatment with proton pump inhibitors for chronic gastritis (up to n = 11 per group) but only one study has investigated patients with GEP-NET, where n = 6 patients with gastric NET were included.

In this study, the investigators aim to assess the time dependent effects of normally ingested diet (5-item English breakfast; or tea or coffee; or ongoing fasted state) on plasma chromogranin A measurements, using timed measurements over 180 min following an \> 10 hours overnight fast, in a randomised double-crossover design. The investigators aimed to include 25 - 35 patients with a histologically confirmed diagnosis of a GEP-NET of varying primary tumour location, tumour stage, grade; and presence or absence of treatment with long acting somatostatin analogues; as well as 10 - 15 healthy controls. In an additional small subgroup of patients who are initiated on treatment with GLP-1 analogues i.e. for type 2 diabetes or obesity, the investigators aim to establish whether injection of GLP-1 analogues has any effects on plasma CgA measurements.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-02-01
• Study First Submitted: 2017-08-10
• Study First Submitted QC: 2017-09-15
• Study First Posted: 2017-09-20
• Primary Completion: 2021-08-10
• Study Completion: 2022-02-10
• Status Verified: 2024-06
• Last Update Submitted: 2024-06-17
• Last Update Posted: 2024-06-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 346

Inclusion Criteria

GEP-NET patients:

• Confirmed diagnosis of NET
• Aged 18 or over
• Able to provide written informed consent
• Able to commit to 3 visits within a 4 week period
• Able to fast overnight
• Able to adequately read/write/speak English

CONTROLS:

• No known diagnosis of NET
• Aged 18 or over
• Able to provide written informed consent
• Able to commit to 3 visits within a 4 week period
• Able to fast overnight
• Able to adequately read/write/speak English

Exclusion Criteria

• GEP-NET patients

• No confirmed diagnosis of a NET
• Under the age of 18
• Unable to provide written informed consent
• Pregnant women
• Any patients who are un well on the day of their routine appointment
• Unable to fast overnight
• Unable to adequately read/write/speak English

CONTROLS

• Confirmed diagnosis of NET
• Under the age of 18
• Unable to provide written informed consent
• Pregnant women
• Any patients who are un well on the day
• Unable to fast overnight
• Unable to adequately read/write/speak English

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
intake of 5 item English breakfast	ongoing fasted state, intake of caffeine containing beverages or 5-item English breakfast	10 h overnight fast; intake of 5-item English breakfast; series blood samples CgA over 180 min
intake of caffeine containing beverages	ongoing fasted state, intake of caffeine containing beverages or 5-item English breakfast	10 h overnight fast; intake of caffeine containing beverages; series blood samples CgA over 180 min
ongoing fasted	ongoing fasted state, intake of caffeine containing beverages or 5-item English breakfast	ongoing fasted following 10 h overnight fast; series blood samples CgA over 180 min

Primary Outcome Measures

Name	Time	Method
changes in plasma CgA measurements related to intake of food or caffeine containing beverages, as compared to ongoing fasted state	up to 180 min	plasma CgA 0, 30, 60, 90, 120, 150 and 180 min

Trial Locations

Locations (1)

The ARDEN NET Centre, ENETS Centre of Excellence; 🇬🇧 Coventry, United Kingdom